Lipids in Health and Disease

Table 5 Input and after treatment values for thyroid function parameters, lipid, apolipoprotein levels, apoA1/apoB ratio, AIP and lipoprotein subclasses in hyperthyroid patients

From: The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism

	Hyperthyroidism
	Before treatment			In euthyreosis
	*Average*	*±SD*	*Min-Max*	*Average*	*±SD*	*Min-Max*	*Signif.*
TC (mmol/l)	3.65	±0.62	2.9-5.0	5.57	±1.08	2.77-6.9	***
TG (mmol/l)	1.0	±0.29	0.6-1.6	1.22	±0.37	0.58-1.81	**
LDL (mmol/l)	2.05	±0.42	1.47-3.21	3.26	±0.77	1.34-4.29	***
HDL (mmol/l)	1.03	±0.22	0.67-1.45	1.38	±0.26	0.93-2.17	***
apoA1 (g/l)	1.56	±0.29	1.10-2.09	1.92	±0.25	1.52-2.6	***
apoB (g/l)	0.61	±0.12	0.42-0.99	0.92	±0.17	0.42-1.15	***
apoA1/apoB	2.59	±0.55	1.90-3.76	2.16	±0.49	1.58-3.79	***
AIP	-0.02	±0.20	-0.33-0.32	-0.07	±0.17	-0.50-0.18	NS
LDL1 (mg/dl)	35.97	±8.29	25-60	53.80	±10.75	25-69	***
LDL2 (mg/dl)	7.00	±2.42	2-12	15.67	±10.17	3-36	***
IDL1 (mg/dl)	11.93	±2.53	6-17	17.33	±5.38	8-26	***
IDL2 (mg/dl)	8.90	±2.58	5-14	12.17	±3.87	4-18	***
IDL3 (mg/dl)	15.47	±4.97	7-27	26.63	±8.27	5-42	***
VLDL (mg/dl)	22.27	±9.32	12-43	35.83	±9.51	20-55	***
Not-normally distributed variables:
	Median	Q3-Q1	Min-Max	Median	Q3-Q1	Min-Max	Signif.
TSH (mIU/l)	0.001	0.0066	0.0025-0.054	2.1	2,22	0.5-4.9	***
fT4 (pmol/l)	55.9	42,28	25.07-138	16.4	4,38	12.1-21.84	***
LDL3-7 (mg/dl)	0	0	0	0	0	4	*

apo – apolipoprotein, AIP – atherogenic index of plasma, Q3-Q1 – interquartile range.
* significantly different via the Student’s t-test or Wilcoxon signed-rank test for non-parametric data: * p < 0.05; ** p < 0.01; *** p < 0.001.

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com